GABA Pharma GABA
Selected indexed studies
- New GABA-Targeting Therapies for the Treatment of Seizures and Epilepsy: II. Treatments in Clinical Development. (CNS Drugs, 2023) [PMID:37603261]
- Neuropathic pain. (Nat Rev Dis Primers, 2017) [PMID:28205574]
- Clinical Pharmacokinetics and Pharmacodynamics of Propofol. (Clin Pharmacokinet, 2018) [PMID:30019172]
_Worker-drafted node — pending editorial review._
Connections
GABA Pharma GABA helps
Sources
- Comparison of amitriptyline supplemented with pregabalin, pregabalin supplemented with amitriptyline, and duloxetine supplemented with pregabalin for the treatment of diabetic peripheral neuropathic pain (OPTION-DM): a multicentre, double-blind, randomised crossover trial. (2022) pubmed
- The Pharmacology and Clinical Efficacy of Antiseizure Medications: From Bromide Salts to Cenobamate and Beyond. (2021) pubmed
- New GABA-Targeting Therapies for the Treatment of Seizures and Epilepsy: II. Treatments in Clinical Development. (2023) pubmed
- Neuropathic pain. (2017) pubmed
- Clinical Pharmacokinetics and Pharmacodynamics of Propofol. (2018) pubmed
- Management of diabetic neuropathy. (2021) pubmed
- Effect of oral γ-aminobutyric acid (GABA) administration on sleep and its absorption in humans. (2016) pubmed
- Relaxation and immunity enhancement effects of gamma-aminobutyric acid (GABA) administration in humans. (2006) pubmed
- Microglia polarization in nociplastic pain: mechanisms and perspectives. (2023) pubmed
- γ1 GABA(A) Receptors in Spinal Nociceptive Circuits. (2024) pubmed